Sign in

CIK 0001021561

  • Accelerated filer

NU SKIN ENTERPRISES, INC.

Sign in to watch
Ticker
NUS
Exchange
NYSE
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870565309
Phone
+1 801-345-1000
Business address
75 WEST CENTER ST, ATTN: GREGORY BELLISTON, PROVO, UT, 84601
Former names
NU SKIN ENTERPRISES INC, NU SKIN ASIA PACIFIC INC, NU SKIN ASIA INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-22 Hatchett Steven Keith Chief Product Officer Grant or award +10,251 58,368
2023-02-22 Clark Chayce David EVP and General Counsel Grant or award +18,090 101,378
2023-02-22 Tang Connie Mang Yee Chief Global Growth Officer Grant or award +13,507 44,324
2023-02-22 Lawrence Mark H Chief Financial Officer Grant or award +19,899 65,249
2023-02-22 NAPIERSKI RYAN S President and CEO Grant or award +53,064 168,784
2023-02-15 Thomas James D Chief Accounting Officer Shares withheld for taxes −1,295 $45.38 $59K 11,427
2023-02-15 Hatchett Steven Keith Chief Product Officer Shares withheld for taxes −1,314 $45.38 $60K 48,117
2023-02-15 Clark Chayce David EVP and General Counsel Shares withheld for taxes −1,303 $45.38 $59K 83,288
2023-02-15 CHANG JOSEPH Y Chief Scientific Officer Shares withheld for taxes −1,981 $45.38 $90K 21,234
2023-02-15 Lawrence Mark H Chief Financial Officer Shares withheld for taxes −2,868 $45.38 $130K 45,350
2023-02-15 Tang Connie Mang Yee Chief Global Growth Officer Shares withheld for taxes −870 $45.38 $39K 30,817
2023-02-15 NAPIERSKI RYAN S President and CEO Shares withheld for taxes −6,963 $45.38 $316K 115,720
2023-02-14 Thomas James D Chief Accounting Officer Grant or award · Employee Stock Option (Right to Buy) +4,819 13,821
2023-02-14 Hatchett Steven Keith Chief Product Officer Grant or award · Employee Stock Option (Right to Buy) +5,649 26,757
2023-02-14 Clark Chayce David EVP and General Counsel Grant or award · Employee Stock Option (Right to Buy) +2,349 6,739
2023-02-14 CHANG JOSEPH Y Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +17,692 83,810
2023-02-14 Lawrence Mark H Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +24,919 118,041
2023-02-14 NAPIERSKI RYAN S President and CEO Grant or award · Employee Stock Option (Right to Buy) +37,751 178,831
2023-01-23 LIPMAN ANDREW D Director Sale −1,000 $42.27 $42K 65,393
2022-12-22 LIPMAN ANDREW D Director Sale −1,000 $40.75 $41K 66,393

Page 10 of 15 · 288 trades